Recon: FDA names Vinay Prasad as CBER director; Vertex halts trial of mRNA treatment for cystic fibrosis
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States